Skip to main content
Premium Trial:

Request an Annual Quote

Althea Wins $100,000 SBIR for New Gene Expression Technology

NEW YORK, May 5 - Althea Technologies said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health, via the National Cancer Institute, to develop a new high-throughput approach to gene expression analysis for cancer.


The $100,000 SBIR project, entitled "Development of a Multiplexed Gene Expression Screen," is based on integrating multiplexed RT-PCR with microarray analysis.


According to the company, this approach can provide a cost per data point as low as one or a few cents per gene.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.